Tricida (NASDAQ: TCDA)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Tricida (NASDAQ: TCDA) through any online brokerage.
Other companies in Tricida’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and Aerie Pharmaceuticals (NASDAQ:AERI).
The latest price target for Tricida (NASDAQ: TCDA) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting TCDA to fall to within 12 months (a possible -70.59% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Tricida (NASDAQ: TCDA) is $13.6 last updated August 12, 2022, 8:00 PM UTC.
The next Tricida (TCDA) dividend date is projected to be Thursday, September 1, 2022.
Tricida’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Tricida.
Tricida is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.